Literature DB >> 17698380

MN1, a novel player in human AML.

Gerard C Grosveld1.   

Abstract

The transcriptional coactivator MN1 has been identified as a gene overexpressed in certain types of human acute myeloid leukemia. Upregulation is invariantly associated with inv(16) AML but is also found in other AML subtypes. Overexpression of this gene is also associated with a worse prognosis and a shorter survival in AML patients with a normal karyotype. In this short review, I will discuss the role of MN1 in myeloid leukemia.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17698380      PMCID： PMC2387274          DOI： 10.1016/j.bcmd.2007.06.009

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN： 1079-9796            Impact factor:   3.039


  26 in total

Review 1.  CREB-binding protein and p300: molecular integrators of hematopoietic transcription.

Authors:  G A Blobel
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

Review 2.  CBP and p300: versatile coregulators with important roles in hematopoietic gene expression.

Authors:  Gerd A Blobel
Journal:  J Leukoc Biol       Date:  2002-04       Impact factor: 4.962

3.  A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells.

Authors:  Yibin Kang; Chang-Rung Chen; Joan Massagué
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

4.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice.

Authors:  Hiroyuki Kawagoe; Gerard C Grosveld
Journal:  Blood       Date:  2005-08-04       Impact factor: 22.113

6.  Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice.

Authors:  James O'Kelly; Junichi Hisatake; Yasako Hisatake; June Bishop; Anthony Norman; H Phillip Koeffler
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

7.  Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.

Authors:  Hiroyuki Kawagoe; Gerard C Grosveld
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

8.  The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription.

Authors:  Karel H M van Wely; Anco C Molijn; Arjan Buijs; Magda A Meester-Smoor; Albert Jan Aarnoudse; Anita Hellemons; Pim den Besten; Gerard C Grosveld; Ellen C Zwarthoff
Journal:  Oncogene       Date:  2003-02-06       Impact factor: 9.867

9.  High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients.

Authors:  Sahar Barjesteh van Waalwijk van Doorn-Khosrovani; Claudia Erpelinck; Wim L J van Putten; Peter J M Valk; Sonja van der Poel-van de Luytgaarde; Ronald Hack; Rosalyn Slater; Elisabeth M E Smit; H Berna Beverloo; Gregor Verhoef; Leo F Verdonck; Gert J Ossenkoppele; Pieter Sonneveld; Georgine E de Greef; Bob Löwenberg; Ruud Delwel
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

10.  Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia.

Authors:  Ya-Huei Kuo; Sean F Landrette; Susan A Heilman; Paola N Perrat; Lisa Garrett; Pu P Liu; Michelle M Le Beau; Scott C Kogan; Lucio H Castilla
Journal:  Cancer Cell       Date:  2006-01       Impact factor: 38.585
View more
  15 in total

1.  Meeting report: Seventh International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia, Annapolis, MD, May 13-16, 2007.

Authors:  Linda Wolff; Steven J Ackerman; Giuseppina Nucifora
Journal:  Exp Hematol       Date:  2008-03-04       Impact factor: 3.084

2.  Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1.

Authors:  Yasuhiko Kamikubo; Ling Zhao; Mark Wunderlich; Takeshi Corpora; R Katherine Hyde; Thomas A Paul; Mondira Kundu; Lisa Garrett; Sheila Compton; Gang Huang; Linda Wolff; Yoshiaki Ito; John Bushweller; James C Mulloy; P Paul Liu
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

3.  MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia.

Authors:  Simone S Riedel; Jessica N Haladyna; Matthew Bezzant; Brett Stevens; Daniel A Pollyea; Amit U Sinha; Scott A Armstrong; Qi Wei; Roy M Pollock; Scott R Daigle; Craig T Jordan; Patricia Ernst; Tobias Neff; Kathrin M Bernt
Journal:  J Clin Invest       Date:  2016-02-29       Impact factor: 14.808

Review 4.  Significance of oncogenes and tumor suppressor genes in AML prognosis.

Authors:  Maria Kavianpour; Ahmad Ahmadzadeh; Saeid Shahrabi; Najmaldin Saki
Journal:  Tumour Biol       Date:  2016-05-14

Review 5.  Differential network analysis in human cancer research.

Authors:  Ryan Gill; Somnath Datta; Susmita Datta
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

6.  The Mn1 transcription factor acts upstream of Tbx22 and preferentially regulates posterior palate growth in mice.

Authors:  Wenjin Liu; Yu Lan; Erwin Pauws; Magda A Meester-Smoor; Philip Stanier; Ellen C Zwarthoff; Rulang Jiang
Journal:  Development       Date:  2008-10-23       Impact factor: 6.868

Review 7.  Clinical implications of molecular genetic aberrations in acute myeloid leukemia.

Authors:  Sebastian Scholl; Hans-Joerg Fricke; Herbert G Sayer; Klaus Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-06       Impact factor: 4.553

8.  MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.

Authors:  N S D Larmonie; T C J M Arentsen-Peters; A Obulkasim; D Valerio; E Sonneveld; A A Danen-van Oorschot; V de Haas; D Reinhardt; M Zimmermann; J Trka; A Baruchel; R Pieters; M M van den Heuvel-Eibrink; C M Zwaan; M Fornerod
Journal:  Oncogene       Date:  2017-09-11       Impact factor: 9.867

9.  An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model.

Authors:  Rachel J Bergerson; Lara S Collier; Aaron L Sarver; Raha A Been; Sanne Lugthart; Miechaleen D Diers; Johannes Zuber; Amy R Rappaport; Molly J Nixon; Kevin A T Silverstein; Danhua Fan; Anne-Francoise J Lamblin; Linda Wolff; John H Kersey; Ruud Delwel; Scott W Lowe; M Gerard O'Sullivan; Scott C Kogan; David J Adams; David A Largaespada
Journal:  Blood       Date:  2012-03-16       Impact factor: 22.113

10.  NKL Homeobox Gene VENTX Is Part of a Regulatory Network in Human Conventional Dendritic Cells.

Authors:  Stefan Nagel; Claudia Pommerenke; Corinna Meyer; Hans G Drexler
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.